- MyIllumina
- Tools
The Mouse LD Linkage Panel consists of 377 SNP loci selected from the Wellcome-CTC Mouse Strain SNP Genotype Set and offers a low-cost, efficient method for attaining genome-wide genetic data to identify quantitative trait loci, map candidate genes, and increase genotyping throughput.
The mouse has been increasingly recognized as an optimal animal for the study of the genetics of complex disease traits. Two Mouse Linkage Panels (Mouse Low Density [LD] Linkage and Mouse Medium Density [MD] Linkage) are available for mouse genetics applications. These single nucleotide polymorphism (SNP) panels offer a low-cost, efficient, method for attaining genome-wide genetic data to identify quantitative trait loci (QTL), map candidate genes, and increase genotyping throughput.
This panel has been optimized for application to N2 and F2 mouse genetics crosses, those typically used for mapping QTLs. It provides approximately 175-200 informative markers per cross and covers the entire mouse genome.
The panel was designed to include approximately four SNPs per 27 Mb interval. At least one SNP in each interval was chosen to be informative in crosses involving the C57Bl/6J strain. On average, at least one SNP in each interval is informative for 85% of all possible strain combinations.
- The Mouse LD Linkage Panel can be used on 12- and 32-sample Universal BeadChips
- SNP sequences are optimized for Illumina's proven GoldenGate Genotyping Assay protocol
Catalog IDs: GT-18-121
View the product support page for additional technical information ยป
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.